FI112474B - Menetelmä kasvainlääkkeinä käyttökelpoisten diaryylialkyylipiperidiiniyhdisteiden valmistamiseksi - Google Patents

Menetelmä kasvainlääkkeinä käyttökelpoisten diaryylialkyylipiperidiiniyhdisteiden valmistamiseksi Download PDF

Info

Publication number
FI112474B
FI112474B FI953506A FI953506A FI112474B FI 112474 B FI112474 B FI 112474B FI 953506 A FI953506 A FI 953506A FI 953506 A FI953506 A FI 953506A FI 112474 B FI112474 B FI 112474B
Authority
FI
Finland
Prior art keywords
tumors
formula
preparation
pct
compounds
Prior art date
Application number
FI953506A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI953506A (fi
FI953506A0 (fi
Inventor
Sai Prasad Sunkara
Jules Freedman
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI953506A publication Critical patent/FI953506A/fi
Publication of FI953506A0 publication Critical patent/FI953506A0/fi
Application granted granted Critical
Publication of FI112474B publication Critical patent/FI112474B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
FI953506A 1993-01-21 1995-07-20 Menetelmä kasvainlääkkeinä käyttökelpoisten diaryylialkyylipiperidiiniyhdisteiden valmistamiseksi FI112474B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US656993A 1993-01-21 1993-01-21
PCT/US1993/012300 WO1994017040A1 (en) 1993-01-21 1993-12-17 Diarylalkyl piperidines useful as multi-drug resistant tumor agents
US9312300 1993-12-17
US656993 1996-05-28

Publications (3)

Publication Number Publication Date
FI953506A FI953506A (fi) 1995-07-20
FI953506A0 FI953506A0 (fi) 1995-07-20
FI112474B true FI112474B (fi) 2003-12-15

Family

ID=21721516

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953506A FI112474B (fi) 1993-01-21 1995-07-20 Menetelmä kasvainlääkkeinä käyttökelpoisten diaryylialkyylipiperidiiniyhdisteiden valmistamiseksi

Country Status (20)

Country Link
US (1) US5648365A (de)
EP (1) EP0680470B1 (de)
JP (1) JP3398748B2 (de)
KR (1) KR100377280B1 (de)
AT (1) ATE150748T1 (de)
AU (1) AU679723B2 (de)
CA (1) CA2152794C (de)
DE (1) DE69309310T2 (de)
DK (1) DK0680470T3 (de)
ES (1) ES2102830T3 (de)
FI (1) FI112474B (de)
GR (1) GR3023188T3 (de)
HU (1) HUT72078A (de)
IL (1) IL108369A (de)
MX (1) MX9400563A (de)
NO (1) NO305166B1 (de)
NZ (1) NZ261414A (de)
TW (1) TW243445B (de)
WO (1) WO1994017040A1 (de)
ZA (1) ZA94317B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2135463T3 (es) * 1992-02-06 1999-11-01 Merrell Pharma Inc Inversion de la resistencia multi-medicamento por medio de derivados de trifenil-piperidina.
AU6366000A (en) * 1999-07-23 2001-02-13 Colorado State University Research Foundation Multidrug resistance pump inhibitors and uses thereof
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US20030109448A1 (en) * 2001-11-07 2003-06-12 Crowley Kathleen S. Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
KR100656490B1 (ko) 2001-11-26 2006-12-12 삼성에스디아이 주식회사 풀칼라 유기전계 발광표시소자 및 그의 제조방법
US8153184B2 (en) * 2001-11-26 2012-04-10 Samsung Mobile Display Co., Ltd. Organic EL display device and method of manufacturing the same
DK3466930T3 (da) 2013-02-08 2022-09-05 Gen Mills Inc Fødevareprodukt med reduceret natriumindhold
CN110372571B (zh) * 2018-04-12 2022-11-15 中国科学院大连化学物理研究所 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1049377B (de) * 1952-04-03 1959-01-29 Abbott Laboratories, North Chicago, 111. (V. St. A.) Verfahren zur Herstellung von substituierten Vinylpiperidinen
US2898339A (en) * 1957-07-29 1959-08-04 Wm S Merrell Co N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US4035372A (en) * 1976-08-13 1977-07-12 G. D. Searle & Co. 4-{[4-(Diphenylmethyl)-1-piperidinyl]methyl}benzenamines
EP0235463A3 (de) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-substituierte Arylalkyl- und Arylalkylen-Piperidine und Anwendung als kardiovaskulär antihistaminische und antisekretorische Mittel
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
US4990511A (en) * 1988-08-03 1991-02-05 Takeda Chemical Industries, Ltd. Amide compounds, their production and use
NZ234110A (en) * 1989-06-19 1993-01-27 Wellcome Found Dibenzoazepine, -oxepine and -cycloheptane substituted alkylidene amines; pharmaceutical compositions containing such compounds or various other aryl substituted amines
GB9000305D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Anticholinergic agents
EP0467435A3 (en) * 1990-07-19 1992-04-01 Akzo N.V. Benzhydryl derivatives having calmodulin inhibitor properties
DE69128820T2 (de) * 1990-08-14 1998-06-10 Hoechst Marion Roussel Inc Neue 19-Nor Steroide, die eine Amid tragende Gruppe in der 11-Beta-Stelle haben, ihre Herstellung, ihre Verwendung als Medikamente und pharmazeutische Präparate davon
ES2135463T3 (es) * 1992-02-06 1999-11-01 Merrell Pharma Inc Inversion de la resistencia multi-medicamento por medio de derivados de trifenil-piperidina.

Also Published As

Publication number Publication date
EP0680470B1 (de) 1997-03-26
NZ261414A (en) 1997-06-24
CA2152794A1 (en) 1994-08-04
ES2102830T3 (es) 1997-08-01
KR960700230A (ko) 1996-01-19
CA2152794C (en) 1999-04-06
WO1994017040A1 (en) 1994-08-04
IL108369A (en) 1999-08-17
GR3023188T3 (en) 1997-07-30
TW243445B (de) 1995-03-21
IL108369A0 (en) 1994-04-12
JPH08505870A (ja) 1996-06-25
AU6014894A (en) 1994-08-15
NO952885D0 (no) 1995-07-20
US5648365A (en) 1997-07-15
MX9400563A (es) 1994-07-29
DK0680470T3 (de) 1997-04-28
ATE150748T1 (de) 1997-04-15
FI953506A (fi) 1995-07-20
DE69309310T2 (de) 1997-11-06
ZA94317B (en) 1994-08-18
EP0680470A1 (de) 1995-11-08
NO305166B1 (no) 1999-04-12
AU679723B2 (en) 1997-07-10
FI953506A0 (fi) 1995-07-20
HUT72078A (en) 1996-03-28
KR100377280B1 (ko) 2003-07-18
DE69309310D1 (de) 1997-04-30
HU9502195D0 (en) 1995-09-28
NO952885L (no) 1995-09-20
JP3398748B2 (ja) 2003-04-21

Similar Documents

Publication Publication Date Title
KR100246154B1 (ko) 수용성 캠프토테신 유도체
FI112474B (fi) Menetelmä kasvainlääkkeinä käyttökelpoisten diaryylialkyylipiperidiiniyhdisteiden valmistamiseksi
DE50010886D1 (de) Neue cyclopropane als cgrp-antagonisten, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA2129144C (en) Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives
RU2060249C1 (ru) Полициклические биоцидные соединения и фармацевтическая композиция на их основе
JPS63170313A (ja) 5−アリール−3h−1,2,4,−トリアゾール−3−オン類の抗痙攣剤としての用途
EP3535239A1 (de) Inhibitoren von mtor-deptor-interaktionen und verfahren zur verwendung davon
US5190957A (en) Treatment of multi-drug resistant tumors with quinolyl-and isoquinolyloxazole-2-ones
EP0428107B1 (de) Verwendung von Chinolyl-und Isochinolyloxazol-2-onen zur Herstellung eines Arzneinmittels zur Behandlung von gegen eine Vielzahl von Arzneimitteln resistenten Tumoren
EP0466586B1 (de) Disubstituierte Polymethylenimine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US3344186A (en) 2-guanidino-1, 2, 3, 4-tetrahydronaphthalene and salts thereof
US6306853B1 (en) 1,4-Dihydropyridine derivatives
US3919311A (en) 3A,12B-Dihydro-8H-dibenzo{8 3,4,6,7{9 cyclohept{8 1,2-d{9 oxazol-8-ones and process for their preparation
EP2260841A2 (de) Verbindungen mit antiparasitäere Aktivität und diese enthaltende Medikamente
JPH0631217B2 (ja) 二環式パーオキサイド